{"pmid":32419930,"pmcid":"PMC7223278","title":"The healthcare and pharmaceutical vulnerability emerging from the new Coronavirus outbreak.","text":["The healthcare and pharmaceutical vulnerability emerging from the new Coronavirus outbreak.","Eur J Hosp Pharm","Leonardi Vinci, Daniele","Polidori, Carlo","Polidori, Piera","32419930"],"journal":"Eur J Hosp Pharm","authors":["Leonardi Vinci, Daniele","Polidori, Carlo","Polidori, Piera"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419930","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/ejhpharm-2020-002278","keywords":["accident & emergency medicine","chemotherapy","drug procurement","health services administration & management","infectious diseases"],"topics":["Prevention"],"weight":1,"_version_":1667159284514816000,"score":9.490897,"similar":[{"pmid":32404493,"title":"COVID-19: some unanswered questions.","text":["COVID-19: some unanswered questions.","Postgrad Med J","Welsby, Philip D","32404493"],"journal":"Postgrad Med J","authors":["Welsby, Philip D"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404493","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1136/postgradmedj-2020-137951","keywords":["epidemiology","health services administration & management","infectious diseases","organisation of health services","public health"],"topics":["General Info"],"weight":1,"_version_":1666802845435822080,"score":88.97363},{"pmid":32133129,"pmcid":"PMC7043250","title":"Houston we have a problem: coronavirus!","text":["Houston we have a problem: coronavirus!","Eur J Hosp Pharm","Wiffen, Philip","32133129"],"journal":"Eur J Hosp Pharm","authors":["Wiffen, Philip"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32133129","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.1136/ejhpharm-2020-002240","keywords":["accident & emergency medicine","audit","basic sciences","intensive & critical care","pain management"],"locations":["Houston"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["General Info"],"weight":1,"_version_":1666138492783034368,"score":56.567993},{"pmid":32371528,"title":"Investigation on cognition of covid-19 and safety during the pandemic among hospital pharmacy staff.","text":["Investigation on cognition of covid-19 and safety during the pandemic among hospital pharmacy staff.","Eur J Hosp Pharm","He, Yan","Li, Wei","Liu, Dong","32371528"],"journal":"Eur J Hosp Pharm","authors":["He, Yan","Li, Wei","Liu, Dong"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371528","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1136/ejhpharm-2020-002314","keywords":["accident & emergency medicine","health & safety","hospital pharmacy competencies","hospital pharmacy education","preventive medicine"],"topics":["Prevention"],"weight":1,"_version_":1666138496405864448,"score":56.109142},{"pmid":32404492,"title":"Point-of-care ultrasound in COVID-19 pandemic.","text":["Point-of-care ultrasound in COVID-19 pandemic.","Postgrad Med J","Bhoi, Sanjeev","Sahu, Ankit Kumar","Mathew, Roshan","Sinha, Tej Prakash","32404492"],"journal":"Postgrad Med J","authors":["Bhoi, Sanjeev","Sahu, Ankit Kumar","Mathew, Roshan","Sinha, Tej Prakash"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404492","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1136/postgradmedj-2020-137853","keywords":["accident & emergency medicine","adult intensive & critical care","ultrasonography"],"topics":["Prevention"],"weight":1,"_version_":1666802845354033152,"score":56.109142},{"pmid":32460133,"title":"Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments.","text":["Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments.","SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents.","Crit Rev Oncol Hematol","Jafari, Anya","Dadkhahfar, Sahar","Perseh, Sahra","32460133"],"abstract":["SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemotherapy drugs, drug interactions are important in these patients especially with SARS-CoV2 treatments now. This paper is review of reported drug interactions of current treatments for COVID-19 and anticancer agents."],"journal":"Crit Rev Oncol Hematol","authors":["Jafari, Anya","Dadkhahfar, Sahar","Perseh, Sahra"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32460133","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.critrevonc.2020.102982","keywords":["covid-19","cancer","chemotherapy","drug interaction","sars-cov2"],"topics":["Treatment"],"weight":1,"_version_":1667967698938626048,"score":54.899162}]}